Monte Rosa Therapeutics, Inc. (GLUE)

NASDAQ: GLUE · IEX Real-Time Price · USD
8.35
0.18 (2.20%)
May 20, 2022 4:00 PM EDT - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year202120202019
Selling, General & Admin
15.734.010.64
Research & Development
57.1624.017.35
Operating Expenses
72.8828.017.99
Operating Income
-72.88-28.01-7.99
Interest Expense / Income
00-0
Other Expense / Income
1.087.87-0.25
Pretax Income
-73.96-35.88-7.74
Net Income
-73.96-35.88-7.74
Net Income Common
-73.96-35.88-7.74
Shares Outstanding (Basic)
2525
Shares Outstanding (Diluted)
2525
Shares Change
1548.09%-69.66%-
EPS (Basic)
-2.96-23.65-1.55
EPS (Diluted)
-2.96-23.65-1.55
Free Cash Flow Per Share
-2.76-17.43-1.51
EBITDA
-71.83-35.34-7.67
EBIT
-73.96-35.88-7.74
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).